Create personalized user journeys with Omnichannel Marketing as a Service.
Empower your marketing operations with AI and Data.
Adopt a future-proof holistic approach to content strategy.
Leverage a suite of professional services for pharma and life sciences.
Develop and enable adaptable pharma and life sciences marketing content.
Enable format-free marketing with content management platform.
End-to-end platform for content validation and sales force readiness.
AI-powered congress engagement coordinator.
Discover our story, values, and how we're making a positive impact
Explore the heart of our organization and meet the visionary minds
Join the Viseven team and grow your career with us
The Viseven team is about respect, diversity, comfortable working conditions, and equal opportunities for everyone. We explore, evolve, and adapt – together.
June 25, 2026 — Bridgewater, New Jersey — We’re thrilled to announce that Viseven is now a Salesforce Content Provider in the expanded Agentforce 360 for Life Sciences ecosystem. Viseven’s collaboration with Salesforce reflects something we’ve believed for a long time: the life sciences industry isn’t just ready to move beyond systems of […]
Viseven, a life sciences technology partner powering the end-to-end commercial content supply chain, announced its participation in the Amazon Web Services (AWS) Independent Software Vendor (ISV) Accelerate Program. The global co-sell initiative connects qualified software partners with AWS sales teams to support joint customer engagement and scalable cloud-based innovation. Through the program, Viseven expands its […]
Viseven, a global digital experiences enabler for the life sciences industry, and drcom, Global-to-Local communication excellence powerhouse, today announced a strategic partnership designed to transform how pharmaceutical and biotechnology companies connect with HCPs and patients. The partnership brings together drcom’s deep expertise in omnichannel healthcare communications and scientific content creation with Viseven’s advanced personalization capabilities, modular content technology, and global delivery infrastructure. Together, Viseven and drcom will enhance […]
October 8, 2025 — Geneva, Switzerland — Viseven, a global leader in digital content solutions for life sciences, and ctcHealth, a pioneer in AI for Pharma Sales & Marketing, today announced a strategic partnership aimed at redefining digital engagement in the pharmaceutical industry. By combining Viseven’s global content development leadership with ctcHealth’s AI-driven expertise, the […]
Last week, something meaningful happened at Viseven. eWizard, our content experience platform built to simplify digital content creation in regulated industries, was named Gold Winner in the Most Innovative Product of the Year (2025) category at the Globee® Achievement Awards. This recognition confirms that our focus on purposeful innovation, grounded in real-world feedback from marketing […]
eWizard, the content experience platform by Viseven, today announces the launch of eVa — a purpose-built AI agent created to meet the demands of marketing and medical teams in the pharmaceutical and life sciences industries. eVa revolutionizes how these teams create, adapt, and validate content by automating complex workflows and significantly accelerating the Medical-Legal-Review (MLR) […]
“Are you unbiased?” It’s a fair question after reading a title like this. The honest answer is not completely. We built eWizard, an AI-powered content supply chain platform, so we naturally have firsthand experience with the challenges pharma teams face and the capabilities that help solve them. That said, this article is not intended to […]
A groundbreaking drug is ready to change lives, but regulatory hurdles, soaring R&D costs, and pricing pressures stand in the way of its success. For the pharmaceutical industry, this scenario is the reality of 2026. With a global talent shortage, aging populations driving up healthcare demands, and supply chains still recovering from recent and ongoing […]
For years, pharma influence was relatively easy to recognize. It lived in congress halls, advisory boards, journal publications, and the voices of respected clinical experts. If a physician, researcher, or professor shaped how others understood a therapy area, they were likely part of the KOL conversation. That model still matters. But it no longer covers […]
